Showing 2,801 - 2,820 results of 36,093 for search '"disease"', query time: 0.12s Refine Results
  1. 2801
  2. 2802
  3. 2803

    Overview of Platelet Physiology: Its Hemostatic and Nonhemostatic Role in Disease Pathogenesis by Kakali Ghoshal, Maitree Bhattacharyya

    Published 2014-01-01
    “…Platelets are also involved in the fundamental biological process of chronic inflammation associated with disease pathology. Platelet indices like mean platelets volume (MPV), platelets distributed width (PDW), and platelet crit (PCT) are useful as cheap noninvasive biomarkers for assessing the diseased states. …”
    Get full text
    Article
  4. 2804
  5. 2805
  6. 2806
  7. 2807
  8. 2808
  9. 2809

    A Comparison of Urine Dilution Ability between Adult Dominant Polycystic Kidney Disease, Other Chronic Kidney Diseases, and Healthy Control Subjects: A Case-Control Study by M. H. Malmberg, F. H. Mose, E. B. Pedersen, J. N. Bech

    Published 2020-01-01
    “…Eighteen ADPKD, 16 non-ADPKD patients (both with chronic kidney disease, stage I-IV), and 18 healthy controls received an oral water load of 20 ml/kg body weight. …”
    Get full text
    Article
  10. 2810

    Effect of Ideal Amino Acid Ratio of Arginine to Lysine on Intake, Nutrient Digestibility, Growth Performance, Antibody Titers of Newcastle Disease and Infectious Bronchitis Disease, and Carcass Characteristics of Broilers by Wahab Liaqat, Urooj Anwar, Asfa Fatima, Azhar Rafique, Riaz Mustafa, Umar Farooq, Faisal Ramzan, Waseem Abbas, Muhammad Farooq Khalid, Muhammad Ashraf, Muhammad Riaz, Muhammad Qamar Bilal, Muhammad Aziz ur Rahman

    Published 2025-01-01
    “…This study aimed to assess the effects of different arginine (Arg) to lysine (Lys) ratios on feed intake, nutrient digestibility, growth performance, carcass characteristics, and antibody titers of Newcastle disease (ND) and infectious bronchitis (IB) disease in broilers during 35 days of trial. …”
    Get full text
    Article
  11. 2811
  12. 2812

    Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial by Remo Panaccione, Edward V Loftus, David Binion, Kevin McHugh, Shamsul Alam, Naijun Chen, Benoît Guérette, Parvez Mulani, Jingdong Chao

    Published 2011-01-01
    “…OBJECTIVE: To evaluate open-label adalimumab therapy for clinical effectiveness, fistula healing, patient-reported outcomes and safety in Canadian patients with moderate to severe Crohn’s disease (CD) who were either naive to or previously exposed to antitumour necrosis factor (anti-TNF) therapy.…”
    Get full text
    Article
  13. 2813
  14. 2814
  15. 2815

    ANALYSIS OF SCHOOLCHILDREN’S HEALTH IN THE MODERN ENVIRONMENT AS EXEMPLIFIED BY POLTAVA REGION by O.D. Sargosh, O.P. Chetverikova

    Published 2017-03-01
    Subjects: “…child population, disease, prevalence of diseases…”
    Get full text
    Article
  16. 2816
  17. 2817
  18. 2818
  19. 2819
  20. 2820